This enduring microburst activity highlights discussion of two experts in COPD and a patient perspective on how to safely and effectively integrate biologics into individualized treatment plans. As a result of this educational curriculum, learners will be better able to: 1. Specify the rationale for targeting eosinophilic inflammation in COPD; 2. Differentiate available & late-stage emerging biologic therapies based on latest clinical evidence in COPD; 3. Identify patients with COPD who are appropriate candidates for biologic therapy; and, 4. Outline strategies to optimally incorporate biologic therapies into treatment plans for patients with COPD. Leaners have access to downloadable materials.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 27 Trinity Place, Suite 185
Pricing
99% of listed courses are free
156 of 157 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General Internal Medicine
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Infectious Disease
- Interventional Cardiology
- Maternal-Fetal Medicine
- Medical Oncology
- Nephrology
- Neurocritical Care
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Infectious Diseases
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Transplant Hepatology
- Urological Oncology
- Urology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pathology & Lab
- Pediatrics
- Primary care
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Microlearning
- includes Online course / module
- Credit · Up to 0.5 credits
- Commercial Support
-
ReleasedDec 30, 2025
-
Last day to claim creditDec 30, 2026 3 months left
-
National Association for Continuing Education Responding to the Science Biologics in Practice in COPD
-
PVI, PeerView Institute for Medical Education Strategies for Incorporating Biologic Therapy Into Individualized COPD Treatment Plans
-
Impact Education +1 Understanding Type 2 Inflammation: Best Practices in COPD Management
-
Answers in CME Inc. (AiCME) Breathing New Life Into the Treatment of COPD With Type 2 Biologics: Personalized Strategies for Evidence-Based Action
-
Answers in CME Inc. (AiCME) COPD Primary Care Playbook: Boosting Diagnosis, Treatment, and Therapy Escalation for Optimal Disease Control
-
National Eczema Association +1 Earlier Biologic Use, Better Pediatric AD Control: Advancing Shared Decision-Making for Enhanced Long-Term Outcomes
